NTRA

#386
Natera, Inc. Common Stock
208.04
-1.88%
版块:
基础:
利润货币:
日范围
208.04
208.52
年范围
125.38
256.27
日变化
-1.88%
每月变动
-13.57%
6个月变化
+27.62%
年变化
+30.03%
前一天收盘价
212.03
Open
208.52
Bid
Ask
Low
208.04
High
208.52
交易量
240
Open full chart

Financials

Overview 声明 Statistics Dividends
Quarterly Annual
  • Market Capitalization 28.44 B
  • Employee 4 434
  • Founded 2004
  • CEO Steven Chapman
  • Website www.natera.com
  • Headquarter Delaware, United States
  • FIGI BBG001J1BQ86
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-150.72
Price to sales ratio
—
Dividends per share
—
Dividend yield %
—

Natera Inc

Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas.

新闻